793 related articles for article (PubMed ID: 15685590)
1. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.
Wenzel J; Schmidt R; Proelss J; Zahn S; Bieber T; Tüting T
Clin Exp Dermatol; 2006 Jul; 31(4):576-82. PubMed ID: 16716166
[TBL] [Abstract][Full Text] [Related]
3. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets.
Wenzel J; Zahn S; Mikus S; Wiechert A; Bieber T; Tüting T
Br J Dermatol; 2007 Oct; 157(4):752-7. PubMed ID: 17714558
[TBL] [Abstract][Full Text] [Related]
4. Type I interferon-associated cytotoxic inflammation in lichen planus.
Wenzel J; Scheler M; Proelss J; Bieber T; Tüting T
J Cutan Pathol; 2006 Oct; 33(10):672-8. PubMed ID: 17026519
[TBL] [Abstract][Full Text] [Related]
5. CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus.
Wenzel J; Proelss J; Wiechert A; Zahn S; Bieber T; Tüting T
J Am Acad Dermatol; 2007 Apr; 56(4):648-50. PubMed ID: 17367614
[TBL] [Abstract][Full Text] [Related]
6. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA.
Wenzel J; Uerlich M; Wörrenkämper E; Freutel S; Bieber T; Tüting T
Br J Dermatol; 2005 Nov; 153(5):1011-5. PubMed ID: 16225615
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
[TBL] [Abstract][Full Text] [Related]
8. Enhanced CCR5+/CCR3+ T helper cell ratio in patients with active cutaneous lupus erythematosus.
Freutel S; Gaffal E; Zahn S; Bieber T; Tüting T; Wenzel J
Lupus; 2011 Oct; 20(12):1300-4. PubMed ID: 21844117
[TBL] [Abstract][Full Text] [Related]
9. IP10/CXCL10 - CXCR3 interaction: a potential self-recruiting mechanism for cytotoxic lymphocytes in lichen sclerosus et atrophicus.
Wenzel J; Wiechert A; Merkel C; Bieber T; Tüting T
Acta Derm Venereol; 2007; 87(2):112-7. PubMed ID: 17340016
[TBL] [Abstract][Full Text] [Related]
10. Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions.
Wenzel J; Bekisch B; Uerlich M; Haller O; Bieber T; Tüting T
Am J Clin Pathol; 2005 Jul; 124(1):37-48. PubMed ID: 15923172
[TBL] [Abstract][Full Text] [Related]
11. Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.
Wenzel J; Zahn S; Bieber T; Tüting T
Arch Dermatol Res; 2009 Jan; 301(1):83-6. PubMed ID: 18784932
[TBL] [Abstract][Full Text] [Related]
12. Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches.
Wenzel J; Tüting T
Exp Dermatol; 2007 May; 16(5):454-63. PubMed ID: 17437489
[TBL] [Abstract][Full Text] [Related]
13. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
14. The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity.
Wenzel J; Henze S; Brähler S; Bieber T; Tüting T
Exp Dermatol; 2005 Jun; 14(6):454-9. PubMed ID: 15885081
[TBL] [Abstract][Full Text] [Related]
15. Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod.
Wenzel J; Uerlich M; Haller O; Bieber T; Tueting T
J Cutan Pathol; 2005 Apr; 32(4):257-62. PubMed ID: 15769273
[TBL] [Abstract][Full Text] [Related]
16. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs.
Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M
Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452
[TBL] [Abstract][Full Text] [Related]
17. Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients.
Reefman E; Kuiper H; Limburg PC; Kallenberg CG; Bijl M
Ann Rheum Dis; 2008 Jan; 67(1):11-18. PubMed ID: 17502354
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage.
Vermi W; Lonardi S; Morassi M; Rossini C; Tardanico R; Venturini M; Sala R; Tincani A; Poliani PL; Calzavara-Pinton PG; Cerroni L; Santoro A; Facchetti F
Immunobiology; 2009; 214(9-10):877-86. PubMed ID: 19625100
[TBL] [Abstract][Full Text] [Related]
19. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production.
Romagnani P; Maggi L; Mazzinghi B; Cosmi L; Lasagni L; Liotta F; Lazzeri E; Angeli R; Rotondi M; Filì L; Parronchi P; Serio M; Maggi E; Romagnani S; Annunziato F
J Allergy Clin Immunol; 2005 Dec; 116(6):1372-9. PubMed ID: 16337473
[TBL] [Abstract][Full Text] [Related]
20. Resolving lesions in human cutaneous leishmaniasis predominantly harbour chemokine receptor CXCR3-positive T helper 1/T cytotoxic type 1 cells.
Geiger B; Wenzel J; Hantschke M; Haase I; Ständer S; von Stebut E
Br J Dermatol; 2010 Apr; 162(4):870-4. PubMed ID: 19906074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
